@article{11883, keywords = {barcode, barcode-assisted medication preparation, medication, preparation, safety, workflow}, author = {Sarah Bledsoe and Alex Van Buskirk and James Falconer and Andrew Hollon and Wendy Hoebing and Sladan Jokic}, title = {Errors detected in pediatric oral liquid medication doses prepared in an automated workflow management system.}, abstract = {

PURPOSE: The effectiveness of barcode-assisted medication preparation (BCMP) technology on detecting oral liquid dose preparation errors.

METHODS: From June 1, 2013, through May 31, 2014, a total of 178,344 oral doses were processed at Children's Mercy, a 301-bed pediatric hospital, through an automated workflow management system. Doses containing errors detected by the system's barcode scanning system or classified as rejected by the pharmacist were further reviewed. Errors intercepted by the barcode-scanning system were classified as (1) expired product, (2) incorrect drug, (3) incorrect concentration, and (4) technological error. Pharmacist-rejected doses were categorized into 6 categories based on the root cause of the preparation error: (1) expired product, (2) incorrect concentration, (3) incorrect drug, (4) incorrect volume, (5) preparation error, and (6) other.

RESULTS: Of the 178,344 doses examined, 3,812 (2.1%) errors were detected by either the barcode-assisted scanning system (1.8%, = 3,291) or a pharmacist (0.3%, = 521). The 3,291 errors prevented by the barcode-assisted system were classified most commonly as technological error and incorrect drug, followed by incorrect concentration and expired product. Errors detected by pharmacists were also analyzed. These 521 errors were most often classified as incorrect volume, preparation error, expired product, other, incorrect drug, and incorrect concentration.

CONCLUSION: BCMP technology detected errors in 1.8% of pediatric oral liquid medication doses prepared in an automated workflow management system, with errors being most commonly attributed to technological problems or incorrect drugs. Pharmacists rejected an additional 0.3% of studied doses.

}, year = {2018}, journal = {Am J Health Syst Pharm}, volume = {75}, pages = {127-131}, month = {12/2018}, issn = {1535-2900}, doi = {10.2146/ajhp160902}, language = {eng}, }